{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:12:54Z","timestamp":1788401574170,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.ppat.1013466","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000}}],"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["ISS #213096"],"award-info":[{"award-number":["ISS #213096"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00c3\u00b3 Lluita contra les Infeccions"},{"name":"NIH\/NIAID","award":["1 UM1 AI164561-01"],"award-info":[{"award-number":["1 UM1 AI164561-01"]}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021 SGR 00452"],"award-info":[{"award-number":["2021 SGR 00452"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["CERCA"],"award-info":[{"award-number":["CERCA"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Despite its efficacy, antiretroviral therapy (ART) is not curative, and HIV-1 rebound occurs whenever treatment is interrupted. The viral reservoir in latently infected cells is the source of the infection resurgence, making it crucial to understand when and how this reservoir is established so that it can be targeted more effectively. In this study, we evaluated the decay dynamics of proviral DNA in 40 ART-naive people initiating dolutegravir-based treatment and compared these dynamics to the decay kinetics of inducible proviruses, as measured using the VIP-SPOT assay. Intensive sampling during the first month, followed by regular sampling up to 48 weeks, enabled us to outline the biphasic decay dynamics of different fractions of the viral reservoir. Our results show that the first decay phase of inducible proviruses is significantly faster than that of total HIV-1 DNA (2.6 days <jats:italic><jats:italic>versus<\/jats:italic><\/jats:italic> 5.1 weeks), indicating that selective pressure on this specific fraction of proviruses is particularly effective during the first days after ART initiation. These findings suggest that therapeutic interventions aimed at impacting the viral reservoir by boosting the immune response targeting the inducible fraction should be implemented at the time of, or immediately before, treatment initiation.<\/jats:p>","DOI":"10.1371\/journal.ppat.1013466","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:45:37Z","timestamp":1757612737000},"page":"e1013466","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-2318","authenticated-orcid":true,"given":"Maria C.","family":"Puertas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Bail\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Urrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Garc\u00eda-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yovaninna","family":"Alarc\u00f3n-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-2129","authenticated-orcid":true,"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the DUALITY study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"ppat.1013466.ref001","unstructured":"HIV and AIDS. World Health Organization. Published 2024. [Accessed November 15, 2024]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"issue":"6756","key":"ppat.1013466.ref002","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"TW Chun","year":"1999","journal-title":"Nature"},{"issue":"24","key":"ppat.1013466.ref003","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral\u2009therapy","volume":"94","author":"T-W Chun","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"ppat.1013466.ref004","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","article-title":"Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection","volume":"95","author":"TW Chun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1013466.ref005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ebiom.2016.07.024","article-title":"HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART","volume":"11","author":"J Ananworanich","year":"2016","journal-title":"EBioMedicine"},{"issue":"7","key":"ppat.1013466.ref006","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","article-title":"Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection","volume":"24","author":"DJ Colby","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"ppat.1013466.ref007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/COH.0000000000000127","article-title":"Very early combination antiretroviral therapy in infants: prospects for cure","volume":"10","author":"K Rainwater-Lovett","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"issue":"17","key":"ppat.1013466.ref008","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1128\/JVI.01046-14","article-title":"Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells","volume":"88","author":"MJ Buzon","year":"2014","journal-title":"J Virol"},{"issue":"7","key":"ppat.1013466.ref009","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/cid\/civ456","article-title":"Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy","volume":"61","author":"M Mart\u00ednez-Bonet","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ppat.1013466.ref010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3851\/IMP2273","article-title":"HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy","volume":"17","author":"C Goujard","year":"2012","journal-title":"Antivir Ther"},{"issue":"3","key":"ppat.1013466.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study","volume":"9","author":"A S\u00e1ez-Ciri\u00f3n","year":"2013","journal-title":"PLoS Pathog"},{"key":"ppat.1013466.ref012","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03821","article-title":"HIV-1 DNA predicts disease progression and post-treatment virological control","volume":"3","author":"JP Williams","year":"2014","journal-title":"Elife"},{"issue":"1","key":"ppat.1013466.ref013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/infdis\/jiaf163","article-title":"Factors Influencing Virologic Control During Analytical Treatment Interruptions in HIV Cure Trials-a Pooled Analysis of Individual-Level Data","volume":"232","author":"V Klastrup","year":"2025","journal-title":"J Infect Dis"},{"issue":"3","key":"ppat.1013466.ref014","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Y-C Ho","year":"2013","journal-title":"Cell"},{"issue":"6","key":"ppat.1013466.ref015","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02417-23","article-title":"HIV reservoirs are dominated by genetically younger and clonally enriched proviruses","volume":"14","author":"NN Kinloch","year":"2023","journal-title":"mBio"},{"issue":"6","key":"ppat.1013466.ref016","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"ppat.1013466.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002615","article-title":"An \u201cescape clock\u201d for estimating the turnover of SIV DNA in resting CD4\u207a T cells","volume":"8","author":"J Reece","year":"2012","journal-title":"PLoS Pathog"},{"issue":"5255","key":"ppat.1013466.ref018","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"issue":"6629","key":"ppat.1013466.ref019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy","volume":"387","author":"AS Perelson","year":"1997","journal-title":"Nature"},{"issue":"5","key":"ppat.1013466.ref020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"D Finzi","year":"1999","journal-title":"Nat Med"},{"issue":"17","key":"ppat.1013466.ref021","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171554","article-title":"The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy","volume":"133","author":"NF McMyn","year":"2023","journal-title":"J Clin Invest"},{"issue":"7742","key":"ppat.1013466.ref022","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"KM Bruner","year":"2019","journal-title":"Nature"},{"issue":"4","key":"ppat.1013466.ref023","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132997","article-title":"Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy","volume":"5","author":"MJ Peluso","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"ppat.1013466.ref024","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/jiaa532","article-title":"Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy","volume":"223","author":"RT Gandhi","year":"2021","journal-title":"J Infect Dis"},{"issue":"6","key":"ppat.1013466.ref025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120326119","article-title":"Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy","volume":"119","author":"JA White","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ppat.1013466.ref026","article-title":"Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing","volume":"119","author":"A Cho","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1013466.ref027","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11904-022-00604-2","article-title":"HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies","volume":"19","author":"EF Kreider","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ppat.1013466.ref028","doi-asserted-by":"crossref","first-page":"686690","DOI":"10.3389\/fmicb.2021.686690","article-title":"Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA","volume":"12","author":"C Lungu","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"ppat.1013466.ref029","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/infdis\/jiae530","article-title":"Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood","volume":"231","author":"L Bail\u00f3n","year":"2025","journal-title":"J Infect Dis"},{"issue":"3","key":"ppat.1013466.ref030","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00560-21","article-title":"VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies","volume":"12","author":"MC Puertas","year":"2021","journal-title":"mBio"},{"issue":"11","key":"ppat.1013466.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009060","article-title":"Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals","volume":"16","author":"S Moron-Lopez","year":"2020","journal-title":"PLoS Pathog"},{"issue":"10","key":"ppat.1013466.ref032","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.0800050105","article-title":"Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy","volume":"105","author":"S Palmer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1013466.ref033","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0000000000000066","article-title":"Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection","volume":"28","author":"MC Puertas","year":"2014","journal-title":"AIDS"},{"issue":"5362","key":"ppat.1013466.ref034","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection","volume":"280","author":"RS Veazey","year":"1998","journal-title":"Science"},{"issue":"9","key":"ppat.1013466.ref035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"KM Bruner","year":"2016","journal-title":"Nat Med"},{"issue":"6193","key":"ppat.1013466.ref036","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"F Maldarelli","year":"2014","journal-title":"Science"},{"issue":"1","key":"ppat.1013466.ref037","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/s41467-020-17898-8","article-title":"Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART","volume":"11","author":"P Gantner","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"ppat.1013466.ref038","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.1522675113","article-title":"Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo","volume":"113","author":"FR Simonetti","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1013466.ref039","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1073\/pnas.98.1.253","article-title":"Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies","volume":"98","author":"TW Chun","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"ppat.1013466.ref040","doi-asserted-by":"crossref","first-page":"14050","DOI":"10.1128\/JVI.01701-14","article-title":"Modeling the timing of antilatency drug administration during HIV treatment","volume":"88","author":"J Petravic","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"ppat.1013466.ref041","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"issue":"5","key":"ppat.1013466.ref042","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/cr.2012.19","article-title":"Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China","volume":"22","author":"M Jia","year":"2012","journal-title":"Cell Res"},{"issue":"513","key":"ppat.1013466.ref043","article-title":"The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation","volume":"11","author":"M-R Abrahams","year":"2019","journal-title":"Sci Transl Med"},{"issue":"7534","key":"ppat.1013466.ref044","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"K Deng","year":"2015","journal-title":"Nature"},{"issue":"2","key":"ppat.1013466.ref045","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01655-23","article-title":"The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time","volume":"98","author":"A Shahid","year":"2024","journal-title":"J Virol"},{"issue":"11","key":"ppat.1013466.ref046","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","article-title":"Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial","volume":"28","author":"JD Gunst","year":"2022","journal-title":"Nat Med"},{"issue":"3","key":"ppat.1013466.ref047","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"KB Einkauf","year":"2019","journal-title":"J Clin Invest"},{"issue":"7824","key":"ppat.1013466.ref048","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct viral reservoirs in individuals with spontaneous control of HIV-1","volume":"585","author":"C Jiang","year":"2020","journal-title":"Nature"},{"issue":"3","key":"ppat.1013466.ref049","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QAD.0000000000001695","article-title":"Wake me up before you go: a strategy to reduce the latent HIV reservoir","volume":"32","author":"N Chomont","year":"2018","journal-title":"AIDS"},{"issue":"6","key":"ppat.1013466.ref050","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1086\/317615","article-title":"Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection","volume":"182","author":"JN Blankson","year":"2000","journal-title":"J Infect Dis"},{"issue":"2","key":"ppat.1013466.ref051","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI97555","article-title":"Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells","volume":"128","author":"S-H Huang","year":"2018","journal-title":"J Clin Invest"},{"issue":"6196","key":"ppat.1013466.ref052","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"TA Wagner","year":"2014","journal-title":"Science"},{"issue":"1","key":"ppat.1013466.ref053","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12977-018-0448-8","article-title":"The role of integration and clonal expansion in HIV infection: live long and prosper","volume":"15","author":"EM Anderson","year":"2018","journal-title":"Retrovirology"},{"issue":"2","key":"ppat.1013466.ref054","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90802-L","article-title":"HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure","volume":"61","author":"JA Zack","year":"1990","journal-title":"Cell"},{"issue":"5030","key":"ppat.1013466.ref055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.1925601","article-title":"Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection","volume":"254","author":"MI Bukrinsky","year":"1991","journal-title":"Science"},{"issue":"5","key":"ppat.1013466.ref056","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/j.1460-2075.1990.tb08274.x","article-title":"HIV-1 replication is controlled at the level of T cell activation and proviral integration","volume":"9","author":"M Stevenson","year":"1990","journal-title":"EMBO J"},{"issue":"1","key":"ppat.1013466.ref057","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/71569","article-title":"Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy","volume":"6","author":"ME Sharkey","year":"2000","journal-title":"Nat Med"},{"issue":"8","key":"ppat.1013466.ref058","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1128\/JVI.79.8.5203-5210.2005","article-title":"In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA","volume":"79","author":"M Sharkey","year":"2005","journal-title":"J Virol"},{"issue":"8","key":"ppat.1013466.ref059","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1128\/JVI.76.8.3739-3747.2002","article-title":"Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles","volume":"76","author":"SL Butler","year":"2002","journal-title":"J Virol"},{"issue":"8","key":"ppat.1013466.ref060","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1128\/JVI.76.8.4138-4144.2002","article-title":"Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication","volume":"76","author":"TC Pierson","year":"2002","journal-title":"J Virol"},{"issue":"17","key":"ppat.1013466.ref061","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1128\/JVI.76.17.8518-8513.2002","article-title":"Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection","volume":"76","author":"TC Pierson","year":"2002","journal-title":"J Virol"},{"issue":"4","key":"ppat.1013466.ref062","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/JVI.79.4.2199-2210.2005","article-title":"Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells","volume":"79","author":"Y Zhou","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"ppat.1013466.ref063","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12977-018-0398-1","article-title":"Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence","volume":"15","author":"J Martinez-Picado","year":"2018","journal-title":"Retrovirology"},{"issue":"1","key":"ppat.1013466.ref064","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/170.1.202","article-title":"Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy","volume":"170","author":"RM Donovan","year":"1994","journal-title":"J Infect Dis"},{"issue":"10","key":"ppat.1013466.ref065","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1128\/JCM.43.10.5272-5274.2005","article-title":"Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia","volume":"43","author":"JL McDermott","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"4","key":"ppat.1013466.ref066","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics","volume":"214","author":"NN Hosmane","year":"2017","journal-title":"J Exp Med"},{"issue":"4","key":"ppat.1013466.ref067","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175899","article-title":"Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue","volume":"12","author":"S Mor\u00f3n-L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"ppat.1013466.ref068","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41467-020-20442-3","article-title":"HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)","volume":"12","author":"NN Kinloch","year":"2021","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1013466","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:51:47Z","timestamp":1758318707000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013466"}},"subtitle":[],"editor":[{"given":"R. Keith","family":"Reeves,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1013466","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}